ArticleTropical animal health and production2026
Evaluation of phyto-therapeutic efficacy of Artemisia annua and Calotropis procera against bovine tropical theileriosis.
Article in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Theileriosis is one of the most important ticks borne hemo-protozoan diseases of cattle causing huge economic losses. The current investigation was undertaken to evaluate therapeutic efficacy and impact on hematological indices and biochemical markers of Artemisia annua L. and Calotropis procera (Aiton) Dryand for the novel treatment of sub-clinical bovine tropical theileriosis. A total 18 sub-clinical theileriosis positive cows were selected and divided randomly into three groups (n = 6). Group I treated with A. annua plant extract @ 100 mg/kg BW PO for six days, group II treated with A. annua plant crude powder @ 1000 mg/kg PO for six days and group III received C. procera flower crude powder @ 100 mg/kg body weight orally 8 doses on alternate days. Clinical study revealed slight increase in body temperature, respiratory and heart rates while hematological analysis revealed decrease in haemoglobin, PCV, platelet count, TEC, TLC and neutrophil and slight increase in percentages of lymphocyte, monocyte, eosinophil and basophil whereas blood biochemical parameters revealed decrease in total serum protein and albumin levels and increase in serum AST, ALT, alkaline phosphatase, creatinine and BUN levels in all sub-clinical theileriosis affected cows. The group I showed 100% efficacy with improvement in clinical parameters and significant improvement in altered PCV, TEC, TLC, monocyte, eosinophil, serum protein and creatinine at 21st day post treatment. However, the drug showed no any adverse effect on liver and kidney function. The group II and III showed 83.67% recovery rate with improvement in clinical parameters and significant improvement in altered platelet count, TLC, neutrophil, monocyte, serum protein, BUN and creatinine levels at 21st day post treatment. It is concluded that Artemisia annua L. plant and Calotropis procera (Aiton) Dryand flowers can be used for treatment of sub-clinical bovine tropical theileriosis in cattle.
Indexed as
Identifiers
41557174What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.